Seres Therapeutics (MCRB) Operating Expenses (2014 - 2026)
Seres Therapeutics (MCRB) posted Operating Expenses of $21.3 million for Q1 2026, up 7.32% sequentially from $19.8 million in Q4 2025, and down 21.92% YoY from $27.2 million in Q1 2025.
Seres Therapeutics (MCRB) Operating Expenses (2014 - 2026) Analysis & Trends
Seres Therapeutics has reported Operating Expenses for 13 years, with the latest figure at $21.3 million in Q1 2026.
- Quarterly Operating Expenses fell 21.92% year-over-year to $21.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $88.8 million (down 22.19% YoY) and the FY2025 annual result came in at $94.8 million, down 21.89% from the prior year.
- Operating Expenses climbed to $21.3 million in Q1 2026 per MCRB's latest filing, from $19.8 million in the prior quarter.
- Over five years, Operating Expenses peaked at $76.9 million in Q2 2023 and troughed at -$4.4 million in Q4 2022.
- A 5-year average of $38.0 million and a median of $29.2 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses sank 107.81% in 2022, then jumped 937.27% in 2023.
- Over 5 years, Operating Expenses stood at -$4.4 million in 2022, then surged by 937.27% to $37.0 million in 2023, then declined by 22.12% to $28.8 million in 2024, then slumped by 31.28% to $19.8 million in 2025, then gained by 7.32% to $21.3 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $21.3 million, $19.8 million, and $22.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Seres Therapeutics | 43.82 Mn | 43.82 Mn | - | 22.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.01 Mn |
| Mar 31, 2026 | 21.27 Mn |
| Dec 31, 2025 | 19.82 Mn |
| Sep 30, 2025 | 22.83 Mn |
| Jun 30, 2025 | 24.88 Mn |
| Mar 31, 2025 | 27.24 Mn |
| Dec 31, 2024 | 28.84 Mn |
| Sep 30, 2024 | 29.17 Mn |
| Jun 30, 2024 | 28.87 Mn |
| Mar 31, 2024 | 34.44 Mn |
| Dec 31, 2023 | 37.02 Mn |
| Sep 30, 2023 | 44.59 Mn |
| Jun 30, 2023 | 76.95 Mn |
| Mar 31, 2023 | 70.05 Mn |
| Dec 31, 2022 | -4.42 Mn |
| Sep 30, 2022 | 62.55 Mn |
| Jun 30, 2022 | 64.54 Mn |
| Mar 31, 2022 | 57.24 Mn |
| Dec 31, 2021 | 56.65 Mn |
| Sep 30, 2021 | 58.32 Mn |